Survival of Rectal Cancer in Yazd, Iran

  • Akhavan, Ali (Department of Radiotherapy, Isfahan University of Medical Sciences) ;
  • Binesh, Fariba (Department of Pathology, Shahid Sadoughi University of Medical Sciences) ;
  • Soltani, Amin (General Practitioner, Shahid Sadoughi University of Medical Sciences)
  • Published : 2014.06.30


Background: Colorectal cancer is common in Iran. However our knowledge about survival of rectal cancer in our province is low. The aim of this study is to evaluate this question. Materials and Methods: Patients with documented pathology of adenocarcinoma of the rectum and rectosigmoid junction referred to our center from September 2004 to September 2012 were enrolled in this study. Metastatic and recurrent patients were excluded. A questionnaire including clinicopathologic parameters, quality and sequence of treatment modalities was filled in for each patient. Patients treated with a combination of surgery, chemotherapy and radiation therapy were divided into standard and non-standard treatment groups, according to the sequence of treatment. Results: One hundred and nineteen patients were evaluated. Mean age was 60.8 year. The median overall survival was 62 months and five year survival was 55%. TNM staging system was not possible due to (Nx) in 21 (17.6%) patients. The others were in stage I, 20 patients (16.8%), II, 35 (29%.5) and III, 43(36.1%). According to our definition only 25 patients (21%) had been treated with standard treatment and 79% had not received it. A five year survival in patients with standard treatment was 85% and in the non-standard group it was 52%.Age, sex, stage and grade of tumor did not show any significant relation to survival. Conclusions: Our study showed a five year survival of rectal cancer in our patients was about 10% lower than the rate which is reported for developed countries. Preoperative concurrent chemoradiation significantly improved local control and even overall survival.


  1. Wei-Jia Fang, Yi Zheng, Li-Ming Wu, et al (2012). Genome-wide analysis of aberrant DNA methylation for identification of potential biomarkers in colorectal cancer patients. Asian Pac J Cancer Prev, 13, 1917-21.
  2. Akhoond MR, Kazemnejad A, Hajizadeh E, Ghanbari Motlagh A (2010). Comparison of colon and rectum cancer: survival and prognostic factors. Gastroenterology Hepatology from Bed to Bench, 3, 177-86.
  3. American Cancer Society. Cancer Facts & Figures (2012). Atlanta: American Cancer Society; 2012.
  4. Azadeh S, Moghimi-Dehkordi B, Fatemi SR, et al (2008). Colorectal cancer in Iran: an epidemiological study. Asian Pac J Cancer Prev, 9, 123-6.
  5. Esna-Ashari F, Sohrabi MR, Abadi AR, et al (2009). Colorectal cancer prevalence according to survival datain Iran-2007. IJCP, 1, 15-18.
  6. Folkesson J, Engholm G, Ehrnrooth E, et al (2009). Rectal cancer survival in the nordic countries and scotland. Int J Cancer, 125, 2406-12.
  7. Ghabeljoo M, Asghari Jafarabadi M, Mohammadi SM, et al (2011). Patterns of survival for anatomical sites of colorectal cancer with shift to advanced lesions in Iran. Asian Pacific J Cancer Prev, 12, 1225-31.
  8. Heidarnia MA, DavoudiMonfared E, Akbari ME, et al (2013). Social determinants of health and 5-year survival of colorectal cancer. Asian Pac J Cancer Prev, 14, 5111-6.
  9. Lee YC, Lee YL,Chuang JP, Lee JC (2013). Differences in survival between colon and rectal cancer from SEER data. PLOS ONE, 8, 78709.
  10. Stewart MD, Parr CL, Lam TH, et al (2013). Behavioural and metabolic risk factors for mortality from colon and rectum cancer: analysis of data from the asia- pacific cohort studies collaboration, Asian Pac J Cancer Prev, 14, 1083-7.
  11. Mahjoubi B, Mirzaei R, Azizi R, Jafarinia M, Zahedi-Shoolami L (2012). A cross-sectional survey of quality of life incolostomates: a report from Iran. Health and Quality of Life Outcomes, 10, 136.
  12. Mehrabani D, Almasi-Hashiani A, MoshfeghiK, Khedmati E (2012). Survival rate and its predictors in colorectal cancer patients, southern Iran. Middle-East J Sci Res, 12, 1072-7.
  13. Moradi A, Khayamzadeh M, GuyaMM, et al (2009). Survival of colorectal cancer in Iran. Asian Pac J Cancer Prev, 10, 583-6.
  14. Rosenberg R, Maak M, Schuster T, et al (2010). Does arectal cancer of the upper third behave more like a colon or a rectal cancer? DisColon Rectum, 53, 761-70.
  15. Safaee A, Moghimi-dehkordi B, Fatemi SR, Ghiasi S, Zali MR (2009). Pathology and prognosis of colorectal cancer. IJCP, 3, 137-41
  16. Salari AA, Moghimi M, Dehghan HR, Karimi H (2008). Evaluation and treatment of colorectal cancer in Yazd - Iran. Asian J Cancer, 7, 31-5.
  17. Sauer R, Liersch T, Merkel S, et al (2012). Preoperative versus postoperative chemoradiotherapy forlocally advanced rectal cancer: results of the german cao/aro/aio-94 randomized phase iii trial after a median follow-up of 11 years. J Clin Oncol, 30, 1926-33.

Cited by

  1. Long Term Outcomes of Preoperative versus Postoperative Concurrent Chemoradiation for Locally Advanced Rectal Cancer: Experience from Ramathibodi Medical School in Thailand vol.16, pp.16, 2015,
  2. Relationships of Colorectal Cancer with Dietary Factors and Public Health Indicators: an Ecological Study vol.16, pp.9, 2015,
  3. Factors Affecting Survival in Patients with Colorectal Cancer in Shiraz, Iran vol.17, pp.1, 2016,
  4. Chemo-Radiation After Upfront Rectal Resections—a Clinical Dilemma pp.0976-6952, 2018,